234 related articles for article (PubMed ID: 9129871)
21. Usefulness of oral nisoldipine for stable angina pectoris. The Nisoldipine Multicenter Angina Study Group.
Frishman WH; Heiman M
Am J Cardiol; 1991 Oct; 68(10):1004-9. PubMed ID: 1927911
[TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacology of nisoldipine coat core.
Zannad F
Am J Cardiol; 1995 Apr; 75(13):41E-45E. PubMed ID: 7726124
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic agents in the management of hypertension--nisoldipine coat-core.
White WB
J Clin Hypertens (Greenwich); 2007 Apr; 9(4):259-66. PubMed ID: 17396068
[TBL] [Abstract][Full Text] [Related]
24. The DEFIANT study of left ventricular function and exercise performance after acute myocardial infarction. Doppler Flow and Echocardiology in Functional Cardiac Insufficiency: Assessment of Nisoldipine Therapy Study Group.
Lewis BS; Poole-Wilson PA
Cardiovasc Drugs Ther; 1994 May; 8 Suppl 2():407-18. PubMed ID: 7947383
[TBL] [Abstract][Full Text] [Related]
25. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
Ehring T; Heusch G
Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
[TBL] [Abstract][Full Text] [Related]
26. A review of amlodipine in myocardial ischaemia.
Taylor SH
Postgrad Med J; 1991; 67 Suppl 5():S48-51. PubMed ID: 1839440
[TBL] [Abstract][Full Text] [Related]
27. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
Waller DG
J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
[TBL] [Abstract][Full Text] [Related]
28. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
29. Doppler flow and echocardiography in functional cardiac insufficiency: assessment of nisoldipine therapy. Results of the DEFIANT-II Study. The DEFIANT-II Research Group.
Eur Heart J; 1997 Jan; 18(1):31-40. PubMed ID: 9049513
[TBL] [Abstract][Full Text] [Related]
30. [Effectiveness of various combination therapies in patients with coronary heart disease].
Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
Herz; 1990 Dec; 15(6):399-409. PubMed ID: 1980660
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Tolerability of Nisoldipine Coat-Core vs Diltiazem Retard in Combination with a Beta-Blocker in Patients with Stable Exertional Angina Pectoris.
Melcher A; Abelin J; Luurila O
Clin Drug Investig; 1998; 15(5):389-96. PubMed ID: 18370494
[TBL] [Abstract][Full Text] [Related]
32. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
Gunasekara NS; Noble S
Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
[TBL] [Abstract][Full Text] [Related]
33. [Nisoldipine in stable angina pectoris. Efficacy and tolerance in comparison with diltiazem].
Kilz U; Knaup G
Fortschr Med; 1991 May; 109(14):309-12. PubMed ID: 2071085
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of amlodipine in the management of ischaemic heart disease.
McGibney D
Postgrad Med J; 1991; 67 Suppl 3():S24-8. PubMed ID: 1836871
[TBL] [Abstract][Full Text] [Related]
35. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
36. Improved diastolic function with the calcium antagonist nisoldipine (coat-core) in patients post myocardial infarction: results of the DEFIANT study. Doppler Flow and Echocardiography in Functional cardiac Insufficiency: Assessment of Nisoldipine Therapy.
Eur Heart J; 1992 Nov; 13(11):1496-505. PubMed ID: 1464339
[TBL] [Abstract][Full Text] [Related]
37. Effect of metoprolol and amlodipine on myocardial total ischaemic burden in patients with stable angina pectoris.
Klein G; Pfafferott C; Beil S; Gehring J; Niemelä M; Kendall MJ
J Clin Pharm Ther; 1997; 22(5-6):371-8. PubMed ID: 19160722
[TBL] [Abstract][Full Text] [Related]
38. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
Brogden RN; Markham A
Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
[TBL] [Abstract][Full Text] [Related]
39. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
[TBL] [Abstract][Full Text] [Related]
40. Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients.
Lopez LM; Rubin MR; Holland JP; Mehta JL
Am Heart J; 1985 Nov; 110(5):991-6. PubMed ID: 3933316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
